Verified
Sarepta Therapeutics
Pharmaceuticals
Founded: Not Available
Headquarters: 215 1st St, Cambridge, Massachusetts, 02142, United States
Overview
Location
Massachusetts, United States
Headquarter
215 1st St, Cambridge, Massachusetts, 02142, United States
Contact Number
(617) 274-4000
No of Employees
1,234 Employees
Industry
Pharmaceuticals
Contact Email
Not Available
Company Type
Public Company
Website
Founded
Not Available
CEO
Douglas Ingram
Codes
SIC Code 28,283 | NAICS Code 32,325
Annual Revenue
$1.9 Billion
Total Funding
$2.8B
Recent Funding Amount
$250M
No of Funding Rounds
17
Company Overview
Established in 1980, Sarepta Therapeutics conducts research on and manufactures pharmaceuticals used to treat genetic diseases. This company is headquartered in Cambridge, Massachusetts.
Employees by Level
C-Level
6
VP-Level
57
Director
1
Manager
370
Non-Manager
504
Top Contacts
1308
Top C-suite Members of Company
Connect with key decision-makers at Sarepta Therapeutics. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Douglas Ingram | Chief Executive Officer & President | d****[email protected] | |
| Diane Berry | Global Health Policy Vice President, Governme | d****[email protected] | |
| Ian Estepan | Executive VP & Chief Financial Officer | i****[email protected] | |
| Nixon Luc | Sciences Director, Manufacturing & Chief Mark | n****[email protected] | |
| Kirsten Meisterling | Senior Director, Chief of Staff To Senior Vic | k****[email protected] | |
| Cris Rothfuss | Executive VP & Chief General Counsel | c****[email protected] | |
| Alison Nasisi | Vice President, Chief People Officer | a****[email protected] | |
| Django Andrews | Executive Director, Legal Chief of Staff & He | d****[email protected] | |
| Ryan Brown | General Counsel | r****[email protected] | |
| Katrina Cahill | Head Vice President, Global Compliance | k****[email protected] | |
| Charles Gerrits | Global Senior VP, Market Access & Innovation | c****[email protected] | |
| Peter O'Hanley | Senior VP, Clinical Development & Regulatory | p****[email protected] | |
| Ian Estepan | Executive VP & Chief Financial Officer | i****[email protected] | |
| Cris Rothfuss | Executive VP & Chief General Counsel | c****[email protected] | |
| Cristin Rothfuss | Senior Vice President, Deputy General Counsel | c****[email protected] | |
| Kirsten Meisterling | Senior Director, Chief of Staff To Senior Vic | k****[email protected] |
Employees Contact
Are you Seeking to connect with decision-makers? Acquire their contact info, including emails and phone numbers, from credible sources like LinkedIn or trusted websites.
| Name | Position | Phone | Profile | |
|---|---|---|---|---|
April Davis | Associate Director, Clinical Development Compliance | ******7714 | [email protected] | |
Erron Deloney | Senior Manager | *******2137 | [email protected] | |
Justin Abrams | Senior Associate, Global Supply Chain And Logistics | ******4385 | [email protected] | |
Michael Krutsinger | Facilities | ******3700 | [email protected] | |
Lisa Conti | Qa Engineer | ******4000 | [email protected] | |
Terry Ashe | Associate Director, East Account Team | ******3700 | [email protected] | |
Christopher Verni | Vp, Chief Intellectual Property Counsel | ******3700 | [email protected] | |
Joe Zenkus | Vice President, Business Development And Strategic Alliances | ******4951 | [email protected] | |
Johannes Dworzak | Duchenne Account Manager | ******3700 | [email protected] | |
Jonathan Platt | Senior Manager, Gene Therapy Ms And T | ******5592 | [email protected] | |
Stephen Dietrich | Senior Associate, Api Process Development And Characterization | ******3700 | [email protected] | |
Josh Haggerty | Talent Acquisition Commercial Hr Partner | ******4000 | [email protected] | |
Jill Murray | Hr Business Partner | ******2500 | [email protected] | |
Kathryn Giblin | Medical Director | ******0270 | [email protected] | |
Marissa Steele | Senior Clinical Research Associate | *******0088 | [email protected] | |
Ken Hawkins | Senior Director, Network Strategy And Planning | ******3234 | [email protected] | |
Valerie Shea | Senior Director, Us Marketing | ******8688 | [email protected] | |
Xiao Ni | Senior Director, Biostatistics | ******4896 | [email protected] | |
Richard Reynolds | Quality Assurance | ******6075 | [email protected] | |
Benjamin Simeone | Director, Gene Therapy Drug Substance Operations | ******2480 | [email protected] | |
Arun Rooj | Scientist Ii | ******0564 | [email protected] | |
Jennifer Cromwell | Senior Environmental, Health And Safety Manager | ******3568 | [email protected] | |
Kevin Kim | Director Of Lead Discovery | ******7027 | [email protected] | |
Anthony Scaccia | Senior Associate, Outsourced | ******0415 | [email protected] | |
Mark Mcgill | Duchenne Account Manager | ******9540 | [email protected] | |
Cindy Gibson | Senior Associate | ******3700 | [email protected] | |
Ju Li | Principal Scientist | ******3700 | [email protected] | |
Douglas Williams | Senior Manager, Compensation | ******1351 | [email protected] | |
Cassie Gray | Rare Disease Nurse Educator -tardis | ******4835 | [email protected] | |
Josanna Holzapfel | Manager Of Subunit Chemistry And Control Account Manager | ******6454 | [email protected] | |
Peter Burch | Associate Director | ******3115 | [email protected] | |
Ashish Dugar | Vice President, Global Medical Affairs | ******3115 | [email protected] | |
Heather Avakemian | Associate Director, Duchenne Account Manager West Team | ******3700 | [email protected] | |
Clarissa Diniz | Associate Director, Us Marketing | ******1661 | [email protected] | |
Mary Smith | Duchenne Reimbursement Manager | ******3700 | [email protected] | |
Stephanie Miller | Duchenne Account Manager | *******2222 | [email protected] | |
Sharon Crugnale | Executive Director, Head Of Clinical Operations | *******7570 | [email protected] | |
Mansi R.ph | Associate Director Pharmacovigilance Operations | ******3030 | [email protected] | |
Ingrid Greene | Purchasing | ******3700 | [email protected] | |
Yifan Zhao | Senior Accountant | *******1117 | [email protected] | |
Liz Smyth | Senior Director Medical Affairs And Msl Team Leader | *******9038 | [email protected] | |
Robert Reddick | Senior Director, Qa Validation And Technical Transfer | ******7709 | [email protected] | |
Cheryl Donahue | Director, National Accounts | ******3700 | [email protected] | |
Julie Poore | Senior Manager, Alliance Operations | *******0000 | [email protected] | |
Jonathan Lu | Medical | ******4000 | [email protected] | |
Courtney Kincaid | Manager, Clinical Trials | ******3700 | [email protected] | |
Tara Clark | Senior Director | *******7041 | [email protected] | |
Derek Rau | Manager | ******3700 | [email protected] | |
Ryan Vogel | Duchenne Account Manager | ******3700 | [email protected] | |
Sharad Wankhade | Associate Director | ******7677 | [email protected] | |
Robert Langevin | Senior Manager, Chief Marketing Officer Support And Technician Transfer | ******4900 | [email protected] | |
Tammy Burke | Senior Director, Global Study Feasibility And Patient Recruitment | ******0028 | [email protected] | |
Janet Howard | Entrepreneur, Mother, Student, Cook And Domestic Goddess | ******3700 | [email protected] | |
Morgan Weeks | Senior Manager, Nucleoside Analytics | ******3700 | [email protected] | |
Emily Chong | Manager, Nucleoside Manufacturing And Proccess Engineering | ******3700 | [email protected] | |
Leanne Winters | Executive Assistant | ******5094 | [email protected] | |
Brock Ueda | Environment, Health And Safety Manager | *******8063 | [email protected] | |
Amy Duncan | Commercial Training | ******3700 | [email protected] | |
Fred D'amato | Director | *******7679 | [email protected] | |
Max Stewart | Translational Development | ******0529 | [email protected] | |
Cindi Crawford | Duchenne Account Manager | ******4827 | [email protected] | |
Simon Zelazo | Associate Director | *******5931 | [email protected] | |
Karen Bulaklak | Senior Scientist - Dmd Gene Editing | *******4601 | [email protected] | |
Elke Blaetz | Director, Global Medical Information | ******8924 | [email protected] | |
Adi Osovsky | Director, Corporate Law | ******5576 | [email protected] | |
Murat Karadeniz | Associate Director, Regulatory Affairs Cmc | *******7570 | [email protected] | |
Jon White | Senior Director, Head Of Underwriting Specialist Sales | ******3700 | [email protected] | |
Leeanna Hoskins | Senior Director - Payer Access | ******3700 | [email protected] | |
Will Tilton | Vice President Corporate Strategy And Program Management | ******8903 | [email protected] | |
Nelsa Estrella | Scientist | ******9403 | [email protected] | |
Damon Asher | Director, Global Medical Affairs, Gene Therapy | ******8581 | [email protected] | |
Steven Lazar | Duchenne Account Manager - Southeast | ******3700 | [email protected] | |
Robin Hall | Associate Manager, Qa Operations | ******0003 | [email protected] | |
Kelly Bourdon | Clinical Trial Manager Ii | ******5533 | [email protected] | |
Dawna Kraft | Case Manager | *******9060 | [email protected] | |
Joe Acosta | Manager, It Systems Operations | ******3700 | [email protected] | |
Daniel Ferreira | Regulatory Cmc | ******6830 | [email protected] | |
Stephanie Stepanchick | Project Manager | ******3700 | [email protected] | |
Richard Azaroff | Senior Validation Engineer | ******3154 | [email protected] | |
Daniela Kropf | Quality Control | ******3700 | [email protected] | |
Alex Park | Director, Regulatory Affairs Cmc | *******9325 | [email protected] | |
Shawn Marlow | Senior Manager, Commercial Operations And Analytics | ******3568 | [email protected] | |
Mary Smith | Duchenne Account Manager | ******3700 | [email protected] | |
Louis Fernandes | Clinical Trial Manager Ii | ******9868 | [email protected] | |
Kaitlin Duffy | Associate Director, Human Resources Business Partner | ******9445 | [email protected] | |
Gunnar Hanson | Research Chemistry | ******3700 | [email protected] | |
Rita Amirana | Senior Director, Global Development Strategy And Clinical Operations | ******7001 | [email protected] | |
Biswarup Dasgupta | Director, Quality Assurance, Gene Therapy | ******7817 | [email protected] | |
Bilal Arif | Vice President, Head Of Strategy And Operations | ******9700 | [email protected] | |
Jill Sullivan | Associate Director, Alliance Management | ******9140 | [email protected] | |
Robert Fay | Facilities | ******3700 | [email protected] | |
Angela Delucco | Associate Director, Talent Acquisition | ******1895 | [email protected] | |
Adam Chevalier | Nucleoside Manufacturing Devolpment | ******3700 | [email protected] | |
David Cory | Director, Learning And Development And Talent | ******1574 | [email protected] | |
John Hohmann | Finance Consultant | *******3094 | [email protected] | |
Alison Nasisi | Senior Director, Global Total Rewards | *******7000 | [email protected] | |
Tammy Griffin | Associate Director, Global Quality Systems | ******6700 | [email protected] | |
Rob Palermo | Market Access At Sarepta Therapeutics | ******3700 | [email protected] | |
Peter Burke | Associate Director, Manufacturing Sciences And Technologies | ******4500 | [email protected] | |
Emily Naughton | Associate Director, Medical Affairs Operations | ******3700 | [email protected] |
Email Formats
Discover the email patterns used at Sarepta Therapeutics to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| [email protected] | [email protected] | 45% |
| [email protected] | [email protected] | 30% |
| [email protected] | [email protected] | 15% |
| [email protected] | [email protected] | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Technology Stack
Frequently Asked Questions
What is the address of Sarepta Therapeutics's headquarters?
Sarepta Therapeutics is headquartered at 215 1st St, Cambridge, Massachusetts, 02142, United States.
How can I contact Sarepta Therapeutics by phone?
You can reach Sarepta Therapeutics by calling their customer support number at (617) 274-4000.
Which stock symbol does Sarepta Therapeutics trade under?
The stock ticker for Sarepta Therapeutics is SRPT.
What is the official website for Sarepta Therapeutics?
You can visit Sarepta Therapeutics's official website at www.sarepta.com.
How much revenue does Sarepta Therapeutics generate?
Sarepta Therapeutics reports an annual revenue of approximately $1.9 Billion.
What is the SIC code for Sarepta Therapeutics?
The Standard Industrial Classification (SIC) code for Sarepta Therapeutics is 28,283.
What is the NAICS code for Sarepta Therapeutics?
Sarepta Therapeutics falls under the NAICS code 32,325.
How many people work at Sarepta Therapeutics?
Sarepta Therapeutics has a workforce of about 1,234 employees.
Which industry is Sarepta Therapeutics part of?
Sarepta Therapeutics operates in the Pharmaceuticals, Healthcare industry.
Which technologies are used by Sarepta Therapeutics?
Sarepta Therapeutics utilizes technologies like BIOVIA, Facebook Web Custom Audiences, Facebook Pixel, DocuSign.
Who is the Chief Executive Officer (CEO) of Sarepta Therapeutics?
The CEO of Sarepta Therapeutics is Douglas Ingram.
How can I get in touch with Sarepta Therapeutics?
To contact Sarepta Therapeutics, call (617) 274-4000 or visit their website at www.sarepta.com
Is Sarepta Therapeutics a publicly traded company?
Yes, Sarepta Therapeutics is publicly listed and trades under the stock symbol SRPT.
How much total funding has Sarepta Therapeutics secured so far?
To date, Sarepta Therapeutics has raised $2.8B across 17 funding round(s).
Who are the main competitors of Sarepta Therapeutics?
Key competitors of Sarepta Therapeutics include Alnylam Pharmaceuticals, Ultragenyx, Ionis Pharmaceuticals, BioMarin
Which companies has Sarepta Therapeutics acquired?
Acquisitions by Sarepta Therapeutics include Ercole Biotech, Myonexus Therapeutics .
Who holds the CFO position at Sarepta Therapeutics?
Ian Estepan serves as the Chief Financial Officer (CFO) at Sarepta Therapeutics.
When did Sarepta Therapeutics complete its most recent funding round?
Sarepta Therapeutics latest funding round closed on Dec 13, 2019 with the amount of $250 Million
Who are the investors in Sarepta Therapeutics?
Sarepta Therapeutics is backed by 19 investors : CureDuchenne, Undisclosed, Undisclosed and Undisclosed.
Generate quality leads for your business
Connect with anyone who has a LinkedIn URL, regardless of their
industry, department, company, or country.
Free Credits to claim
No credit card needed
Instant leads result